Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Opevesostat is an inhibitor of the cytochrome P450 (CYP) isoform CYP11A1 (IC50 = 20.4 nM), the enzyme that catalyzes the first committed step of steroid hormone biosynthesis by converting cholesterol (Item Nos. 9003100 | 39088 | 39448) to pregnenolone (Item No. 19864).1 It is selective for CYP11A1 over CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4/5 at 10 µM.
WARNING This product is not for human or veterinary use.
1. Design, synthesis, and biological evaluation of cytochrome P450 CYP11A1 inhibitors. Bioorg. Med. Chem. 135, 130567 (2026).